We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
We are excited to share that West has been named the winner for Excellence in Fill & Finish at the Asia Pacific Vaccine Excellence Awards 2021 (AVEA 2021).
AVEA 2021 aimed to celebrate the outstanding achievements of biopharmaceutical organizations, supply chain experts, and the newest technology solutions deployed in Asia for the development and distribution of vaccines. The award ceremony was held in association with the 3rd Vaccine World Asia Congress 2021 on November 17-18, attracting more than 800 representatives from Asia’s top vaccine and supply chain organizations.
West stood out among the five nominees for our technology and high quality products, services, and solutions that have helped to bring vaccines and therapeutics to the market and patients, especially those related to COVID-19.
During the pandemic, vaccine developers have trusted West as a partner of choice to help protect their sensitive biomolecules, and this award recognizes our critical role in the race to deliver vaccines at a high level of efficacy, quality, and safety.
“We are honored to receive this award. It is a true testament to West’s almost 100 years of experience and reputation for leadership in quality, as well as the great efforts of One West Team coming together on the mission of improving patient lives,” said Stewart Campbell, Vice President & General Manager, Asia Pacific.
Click here to learn more about West’s containment and delivery solutions that help to support a healthier world.
<span>There’s nothing like a good old-fashioned bake sale to raise money for your favorite cause. </span>
In March, West presented the Sri Shankara Cancer Hospital with a donation at the opening of West Digital Technology Center (DTC) in Bengaluru, India. These funds will support patients who need financial assistance and who would otherwise not be able to afford their cancer treatment.
Organizations today are far more vulnerable to cyber threats due to the digital information and technology that are so heavily integrated into the daily workplace. The attacks themselves, which target both information and critical infrastructure, are becoming far more sophisticated.
To continue to learn and innovate is truly a daunting task. The journey to success has many ups and downs, but the end of that journey is not necessarily about knowing what worked or did not, but what to do with those learnings. In West’s journey to becoming a world leader in integrated containment and delivery (i.e., our learning experience), we continue to focus on market needs and listen to the voice of the customer. There are few better places to engage with customers and learn about the state of an industry than a trade show or conference. Below are some learnings (Part 1) – first-hand accounts of changes and trends that are shaping the pharmaceutical landscape that have been the topic of conversation at recent shows. Stay tuned for Parts 2 and 3.<p> </p>
Protein-based therapeutics are examples of the advancement of modern medicine and a revolution in drug discovery. Monoclonal antibodies (mAbs) account for the majority of biologic FDA approvals, and due to their low bioavailability by oral delivery means, they necessitate a shift to parenteral delivery. Hence, mAbs are typically packaged and stored in liquid or lyophilized format in glass vials, prefilled syringes, or cartridges for later injection.<br />
English
Chinese
